BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15040582)

  • 1. Human antibody-Fc receptor interactions illuminated by crystal structures.
    Woof JM; Burton DR
    Nat Rev Immunol; 2004 Feb; 4(2):89-99. PubMed ID: 15040582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fc Receptor Variants and Disease: A Crucial Factor to Consider in the Antibody Therapeutics in Clinic.
    Kim J; Lee JY; Kim HG; Kwak MW; Kang TH
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Fc function for rational vaccine design against pathogens.
    Bowman KA; Kaplonek P; McNamara RP
    mBio; 2024 Jan; 15(1):e0303623. PubMed ID: 38112418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc receptors as adaptive immunoreceptors.
    Daëron M
    Curr Top Microbiol Immunol; 2014; 382():131-64. PubMed ID: 25116099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: New functional separation and analysis technologies utilizing human Fc receptors.
    Schlothauer T; Reusch D; Wuhrer M
    Front Immunol; 2024; 15():1434438. PubMed ID: 38903519
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Biburger M
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing antibody-Fc-receptor interactions.
    Nimmerjahn F; Ravetch JV
    Methods Mol Biol; 2008; 415():151-62. PubMed ID: 18370153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG subclasses and allotypes: from structure to effector functions.
    Vidarsson G; Dekkers G; Rispens T
    Front Immunol; 2014; 5():520. PubMed ID: 25368619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phylogenetic diversification of immunoglobulin genes and the antibody repertoire.
    Litman GW; Rast JP; Shamblott MJ; Haire RN; Hulst M; Roess W; Litman RT; Hinds-Frey KR; Zilch A; Amemiya CT
    Mol Biol Evol; 1993 Jan; 10(1):60-72. PubMed ID: 8450761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for Fc gammaRIIa recognition of human IgG and formation of inflammatory signaling complexes.
    Ramsland PA; Farrugia W; Bradford TM; Sardjono CT; Esparon S; Trist HM; Powell MS; Tan PS; Cendron AC; Wines BD; Scott AM; Hogarth PM
    J Immunol; 2011 Sep; 187(6):3208-17. PubMed ID: 21856937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants of unique properties of human IgG4-Fc.
    Davies AM; Rispens T; Ooijevaar-de Heer P; Gould HJ; Jefferis R; Aalberse RC; Sutton BJ
    J Mol Biol; 2014 Feb; 426(3):630-44. PubMed ID: 24211234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.
    Hogarth PM; Pietersz GA
    Nat Rev Drug Discov; 2012 Mar; 11(4):311-31. PubMed ID: 22460124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.
    Kaneko Y; Nimmerjahn F; Ravetch JV
    Science; 2006 Aug; 313(5787):670-3. PubMed ID: 16888140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
    Tsuchikama K; An Z
    Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hinge-engineered IgG1-IgG3 hybrid subclass IgGh
    Izadi A; Karami Y; Bratanis E; Wrighton S; Khakzad H; Nyblom M; Olofsson B; Happonen L; Tang D; Sundwall M; Godzwon M; Chao Y; Toledo AG; Schmidt T; Ohlin M; Nilges M; Malmström J; Bahnan W; Shannon O; Malmström L; Nordenfelt P
    Nat Commun; 2024 Apr; 15(1):3600. PubMed ID: 38678029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a membrane Fcγ receptor in largemouth bass (Micropterus saloumoides) and its response to bacterial challenge.
    Wang J; Wu J; Ma Y; Hao L; Huang W; Liu Z; Li Y
    Fish Physiol Biochem; 2024 Jun; 50(3):1123-1140. PubMed ID: 38407736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant neutralizing secretory IgA antibodies for preventing mucosal acquisition and transmission of SARS-CoV-2.
    Göritzer K; Groppelli E; Grünwald-Gruber C; Figl R; Ni F; Hu H; Li Y; Liu Y; Hu Q; Puligedda RD; Jung JW; Strasser R; Dessain S; Ma JK
    Mol Ther; 2024 Mar; 32(3):689-703. PubMed ID: 38268188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the Linear Fc-Binding Site on the Bovine IgG1 Fc Receptor (boFcγRIII) Using Synthetic Peptides.
    Wang R; Guo J; Li G; Wang X; Yang J; Li Q; Zhang G
    Vet Sci; 2024 Jan; 11(1):. PubMed ID: 38250930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclass-switched anti-spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization.
    Izadi A; Hailu A; Godzwon M; Wrighton S; Olofsson B; Schmidt T; Söderlund-Strand A; Elder E; Appelberg S; Valsjö M; Larsson O; Wendel-Hansen V; Ohlin M; Bahnan W; Nordenfelt P
    Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2217590120. PubMed ID: 37011197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.